Announcement of Important Resolutions of the 2022
Annual General Meeting of Shareholders of the Company
Date of events
2022/06/29
To which item it meets
paragraph 18
Statement
1.Date of the shareholders' meeting:2022/06/29
2.Important resolutions I.Profit distribution/deficit compensation:
2021 Earnings Distribution
3.Important resolutions II.Amendments of the company charter:
Amendments of "Articles of Incorporation"
4.Important resolutions III.Business report and financial statements:
2021 Business Report and Financial Report
5.Important resolutions IV.Election for directors and supervisors:
None
6.Important resolutions V.Other matters:
(1)Amendments to the "Operational Procedures for
Acquisition or Disposal of Assets"
(2)Amendments to the "Endorsement Guarantee
Management Measures"
(3)Amendments to the "Management Measures of
Loan to Others"
(4)Amendments to the "Rules of Procedure for
Shareholders' Meetings"
(5)Amendments to the "Method of Election of Directors"
(6)In conjunction with the future stock listing
application of our subsidiary, TCI Gene Inc., the Company
intended to release shares of the company and abstain
from participating in the cash capital increase plan
of the company.
7.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
TCI Co. Ltd. published this content on 29 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 June 2022 13:48:10 UTC.
TCI Co Ltd is a Taiwan-based company principally engaged in the research, development, manufacture and sale of functional beverages, health foods and beauty care products. The health food includes various types of food, such as hard capsules, soft capsules, pastilles, powder, liquid packs, jelly and oil-based hard gelatine. The beauty care products include facial and body care products, such as facial masks, eye masks, facial cleansers, anti-acne gel, whitening cream, slimming cream, breast enhancement cream and serum. In addition, the Company is engaged in the production and sale of biological products, various medical devices and confidential chemical materials. The Company distributes its products in domestic market and to overseas markets.